|
Manchester International Holdings Unlimited Corporation - Sales Analysis Snapshot
Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Manchester International Holdings Unlimited Corporation Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.
Manchester International Holdings Unlimited Corporation Formerly known as Interphil Laboratories, Inc.. The Company's principal activity is manufacturing, processing and packaging drugs, chemicals, pharmaceuticals, and veterinary products. The Group product lines cover dry products, liquid products, cream and ointments, sterile products and beta lactams. Products include plain tablets, sugar or film-coated tablets, powder and pellet-filled capsules, syrups, solutions, suspensions, emulsions, suppositories, creams, pastes, ointments, lotions, gels, injectibles, eye drops, nasal drops and sprays dental anaesthetics sterile ointments, capsules and powder oral suspension. The Group also produces confectionery, balms and pomade products. The Group products are exported to Taiwan, China, Hong Kong, Malaysia, Singapore, Thailand, Australia and New Zealand.
Not the Report you are looking for? Click here for more browsing options.
Layout and Content of a Typical Report
|
